COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series
新冠疫苗在免疫抑制成人自身免疫性风湿病患者中的应用（COVIAAD）：Moderna Spikevax 基础免疫接种后 12 个月的安全性、免疫原性和抗体持久性
期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2023-003400
Colmegna, Ines; Valerio, Valeria; Amiable, Nathalie; Useche, Mariana; Rampakakis, Emmanouil; Flamand, Louis; Rollet-Labelle, Emmanuelle; Bessette, Louis; Fitzcharles, Mary-Ann; Hazel, Elizabeth; McCormack, Deirdre; Michou, Laëtitia; Panopalis, Pantelis; Langlois, Marc-André; Bernatsky, Sasha; Fortin, Paul R
